Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications

The Histochemical Journal

Volumn 25, Issue 12, 1993, Pages 843-853

  Yu, Carmen C W ^a   Filipe, M Isabel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67;

ADULT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVIEW;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CELL DIVISION; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0027135951     PISSN: 00182214     EISSN: 15736865     Source Type: Journal    
DOI: 10.1007/BF02388205     Document Type: Review

References (71)

1. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining
2. Proliferating cell nuclear antigen expression in central nervous system neoplasms
3. Tumour suppressor gene products, proliferation and differentiation markers in lung neuroendocrine neoplasms
4. Growth regulation of the PCNA gene
5. Correlation of proliferative activity in breast tissue using PCNA/cyclin (letter)
6. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle. Association with DNA replication sites
7. Monoclonal antibody Ki-67: its use in histopathology
8. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells
9. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells
10. Expression of proliferating cell nuclear antigen in lung cancer: a systematic study and correlation with DNA ploidy
11. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwaveprocessed formalin-fixed paraffin sections
12. Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair
13. Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues
14. Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognised by the Ki-67 monoclonal antibody
15. Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance
16. p53 overexpression in gastric carcinoma is a prognostic indicator
17. Assignment of the human Ki-67 gene (MK167) to 10q25-qter
18. Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology
19. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animals and human tissues
20. Production of a monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
21. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67
22. Molecular cloning of the human Ki-67 gene (MKI-67)
23. Epithelial proliferation in Barrett's oesophagus by proliferating cell nuclear antigen immunolocalisation
24. An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues
25. Proliferating cell nuclear antigen (PCNA) immunolocalisation in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms
26. High levels of p53 protein in UV irradiated normal human skin
27. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters
28. Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy
29. Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products
30. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma
31. Proliferating cell nuclear antigen in oesophageal diseases: correlation with transforming growth factor alpha expression
32. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin
33. Regulation of the proliferating cell nuclear antigen/cyclin and thymidine kinase mRNA levels by growth factors
34. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlations with Ki-67 labeling
35. Immunocytochemical identification of proliferative hepatocytes using monoclonal antibody to proliferating cell nuclear antigen (PCNA/cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha
36. Detection of proliferating hepatocytes by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) in patients with acute hepatic failure
37. New Ki-67 equivalent murine monoclonal antibodies (MIB 1–3) prepared against recombinant parts of the Ki-67 antigen
38. A new proliferation associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1
39. Antibodies to proliferative cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis
40. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables
41. Clinical application of morphologic and immunocytochemical assessments of cell proliferation
42. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value
43. The complexities of proliferating cell nuclear antigen
44. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1
45. The relevance of antibody concentration to the immunohistological quantitation of cell proliferation associated antigens
46. Assessment of rejection of orthotopic human heart transplantation using proliferating cell nuclear antigen (PCNA) as an index of cell proliferation
47. Autoantibody to a nuclear antigen in proliferating cells
48. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication
49. The promoter of the proliferating cell nuclear antigen (PCNA) gene is active in serum-derived cells
50. Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumours of the pancreas
51. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis
52. Analysis of the epitopes of proliferating cell nuclear antigen recognised by monoclonal antibodies
53. Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA)
54. KiS1-a novel monoclonal antibody which recognises proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma
55. Ki67-Structure, function and new antibodies
56. Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's Disease
57. Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma
58. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction
59. Proliferating cell nuclear antigen is required for DNA excision repair
60. Proliferating cell nuclear immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer
61. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody
62. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen
63. Proliferating cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small cell lung carcinoma
64. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis
65. Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study
66. Replication factors required for SV40 DNA replication in vitro. 1. DNA structure-specific recognition of a primer-template junction by eukaryotic DNA polymerases and their accessory proteins
67. Replication factors required for SV40 DNA replication in vitro. Ii. Switching of DNA polymerase alpha and delta during initiation of leading and lagging strand synthesis
68. Nuclear distribution of the Ki-67 antigen during the cell cycle: Comparison with growth fraction in human breast cancer cells